United Immunity entered into a master clinical supply agreement with Roche to evaluate UI-102 in combination with an ...

GLOBE pilot’s underwhelming scale; Sanofi and Regeneron expand immunology investments; China’s five-year plan for global ...

Tariffs squeeze small and midsized biotechs; Eli Lilly notches another impressive weight loss drug readout; Lawmakers warn ...

Eight physicians will review content, shape products and open doors to industry partners in what is planned to be very active ...

As another death row inmate’s execution approaches, doctors and nurses in the state say they want medical professionals ...

Biopharmaceutical company Neurocrine Biosciences has selected Ruder Finn as its communications agency of record. The ...

In Merck’s latest campaign for HIV, the company wants to lean into a cultural conversation to help consumers connect with the ...

FDA approves Lilly’s weekly insulin shot; Study finds tobacco industry spammed FDA comments opposing menthol cigarette ban; ...

The overhaul of GLP-1 marketing; The MAHA split ahead of the midterms; Roche and the future of AI in medicine.

In this episode, industry leaders from Syneos Health, Joe Daley and Matthew Snodgrass, introduce a new definition of success ...

In this episode, we explore how healthcare organizations can work with patient, consumer and HCP creators to build influence ...

The FDA approved Ultragenyx Pharmaceutical’s Fayuvi (rebisufligene etisparvovec-hopf), the first treatment for children with ...